Pediatric safety proof container stirs controversy

Published: 2007-06-15 06:56:00

Updated: 2007-06-15 06:56:00

The non-observance of some drug makers, who failed to attach the safety proof container for pediatric drugs, has triggered controversy, according to pharmaceutical business sources on June 12.

The sources said that a variety of dispensing-oriented OCT OTC products in larger packets (1,500 tabl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK